We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

78 hedge funds and large institutions have $185M invested in BioSpecifics Technologies Corp. in 2018 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 28 increasing their positions, 31 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $176M → $185M (+$9.37M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

10% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 31

11% less funds holding

Funds holding: 88 → 78 (-10)

53% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 17

Holders
78
Holders Change
-10
Holders Change %
-11.36%
% of All Funds
1.79%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
8
Increased
28
Reduced
31
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$8.57M
2
Renaissance Technologies
Renaissance Technologies
New York
+$2.3M
3
TAM
THB Asset Management
Connecticut
+$1.95M
4
AL
AJO LP
Pennsylvania
+$1.48M
5
BCM
Bridgeway Capital Management
Texas
+$1.2M

Top Sellers

Rank Fund Capital Flow
1
NC
Northpointe Capital
Michigan
-$3.5M
2
MOACM
Mutual of America Capital Management
New York
-$2.4M
3
BlackRock
BlackRock
New York
-$2.06M
4
ACM
Ativo Capital Management
Illinois
-$1.43M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
26
Wellington Management Group
Massachusetts
$1.74M -$1.16M -27,520 -41%
Man Group
27
Man Group
United Kingdom
$1.66M +$1.57M +37,423 New
MCM
28
Matarin Capital Management
New York
$1.5M -$637K -15,172 -31%
TCIM
29
TIAA CREF Investment Management
New York
$1.44M +$296K +7,040 +28%
CAM
30
ClariVest Asset Management
California
$1.4M +$12.6K +300 +1%
BCM
31
Bridgeway Capital Management
Texas
$1.26M +$1.2M +28,500 New
Morgan Stanley
32
Morgan Stanley
New York
$1.19M -$75.9K -1,806 -6%
First Manhattan
33
First Manhattan
New York
$1.17M -$164K -3,900 -13%
Millennium Management
34
Millennium Management
New York
$1.09M +$365K +8,698 +55%
Invesco
35
Invesco
Georgia
$940K -$806K -19,193 -47%
IP
36
Isthmus Partners
Wisconsin
$824K +$49.4K +1,177 +7%
Two Sigma Investments
37
Two Sigma Investments
New York
$797K +$69.3K +1,651 +10%
SCA
38
Secor Capital Advisors
New York
$753K +$5.08K +121 +0.7%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$744K – – –
Two Sigma Advisers
40
Two Sigma Advisers
New York
$683K – – –
SGI
41
Summit Global Investments
Utah
$616K +$584K +13,900 New
SO
42
STRS Ohio
Ohio
$576K – – –
American Century Companies
43
American Century Companies
Missouri
$497K -$9.87K -235 -2%
D.E. Shaw & Co
44
D.E. Shaw & Co
New York
$463K +$37.8K +900 +9%
CIBC Private Wealth Group
45
CIBC Private Wealth Group
Georgia
$460K -$51.7K -1,230 -11%
TA
46
Teachers Advisors
New York
$448K – – –
Russell Investments Group
47
Russell Investments Group
United Kingdom
$431K +$354K +8,423 +640%
PPA
48
Parametric Portfolio Associates
Washington
$414K +$392K +9,335 New
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$382K -$12.7K -302 -3%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$337K -$72K -1,713 -18%
1
2
3 4

BSTC Hedge Fund Activity: Q1 2018 in Review

78 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q1 2018, worth a combined $185M — up 5.3% from $176M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of BSTC and 8 opened new positions — a net loss of 9 holders — while 31 trimmed existing stakes and 28 added.

The largest buyer was Stonepine Capital Management, adding an estimated $8.57M. The largest seller was Northpointe Capital, exiting entirely with an estimated $3.5M sold.

  • 78 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q1 2018, down from 88 in Q4 2017.
  • Funds reported $185M of BioSpecifics Technologies Corp. stock for Q1 2018, up 5.3% quarter-over-quarter.
  • 8 funds opened new BioSpecifics Technologies Corp. positions in Q1 2018 and 17 closed out, a net change of -9 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q1 2018 was Stonepine Capital Management, an estimated $8.57M added.
  • The largest BioSpecifics Technologies Corp. seller in Q1 2018 was Northpointe Capital, an estimated $3.5M sold.

Based on aggregated 13F filings for Q1 2018.